Abstract PD2-05: Randomized phaseII trial to evaluate alisertib alone or combined with fulvestrant for advanced, endocrine-resistant breast cancer (TBCRC 041)Tufia Haddad, Antonino D'Assoro,Vera Suman,Jodi Carter, Brendan McMenomy,Erica Mayer, Meghan Karuturi, Aki Morikawa, Paul Marcom,Claudine Isaacs,Sun Young Oh,Amy Clark,Ingrid Mayer,Khandan Keyomarsi,Roberto Leon-Ferre,Karthik Giridhar,Ciara O'Sullivan, Prema Peethambaram, Timothy Hobday,Minetta Liu,James Ingle,Matthew GoetzCancer Research（2021）引用 1|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
